A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650)

• Status: Completed
• Trial end date: 2009-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and tolerability of INS117548 ophthalmic solution.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Ophthalmic Solutions

Criteria

Inclusion Criteria:

• Have a diagnosis of bilateral ocular hypertension or early primary open angle glaucoma

• Have best corrected visual acuity in both eyes of at least +0.5 or better

Exclusion Criteria:

• Are diagnosed with closed angle glaucoma, exfoliation syndrome or exfoliation glaucoma, and pigment dispersion or secondary glaucoma

• Have a history of any type of intraocular surgery, except for cataract surgery

• Have had cataract surgery within three months